Catheter PrecisionVTAK

13F holders, Q2 2026 (June 30)
10holders −2
1new positions
3sold out
$0.85avg. 13F price*

At the end of Q2 2026, 10 institutions reported holding Catheter Precision Inc. (VTAK) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 3 sold out. The largest holders were Virtu Financial LLC ($17K), UBS Group AG ($14K) and Geode Capital Management, LLC ($10K).

Company
Catheter Precision Inc.
CUSIP
74933X708
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q3 2025: 3Q3 2025Q4 2025: 9Q4 2025Q1 2026: 12Q1 2026Q2 2026: 10Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions1$7K
Exits3$36K

All 13F filers, Q1 2026 → Q2 2026: 36,810 shares bought and 71,474 shares sold, net −34,664 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 10 holders

Virtu Financial LLC 0.00% Add +47.4% 19,861 $17K
UBS Group AG 0.00% Add +2147.8% 17,061 $14K
Geode Capital Management, LLC 0.00% Reduce -74.9% 11,977 $10K
Tower Research Capital LLC (TRC) 0.00% Add +142.7% 9,452 $8K
Osaic Holdings, Inc. 0.00% New 8,540 $7K
Allworth Financial LP 0.00% No change 300 $255
Citigroup Inc. 0.00% Add +2100.0% 22 $19
Purpose Unlimited Inc. 0.00% No change 13 $9
Harbour Investments, Inc. 0.00% No change 8 $7
SBI Securities Co., Ltd. 0.00% No change 5 $4

"% of holder's portfolio" is VTAK's weight in each manager's 13F, not the share of Catheter Precision Inc. the manager owns.